| Daily Alerts |
| Results |
| HDFC Bank: Stable trends |
| | Stable performance aided by cost control and low credit cost | | | Retail loan growth momentum continues | | | Retain ADD with TP of Rs1,400 (from Rs1,350) | |
| Axis Bank: The pain increases |
| | Weak overall performance; positive trends on retail front | | | Slippages from watchlist rises sharply; slippage also seen in foreign currency exposure | | | Operating profit growth to be under pressure; valuation discomfort leads to our negative view | |
| Bharti Airtel: 2QFY17 ahead of estimates; takes Board approval for BHIN stake sale |
| | 2QFY17 earnings print - fine on most counts | | | Board approval for monetization of stake in Bharti Infratel | |
| Bharti Infratel: Remains a good compounding bet |
| | Key changes to our earnings model | | | Takeaways from the earnings call | | | Target price stands revised to Rs410/share on rollover to Sep 2018E, retain ADD | |
| Adani Port and SEZ: Stellar quarter |
| | 2QFY17: Share gains in container, SEIS income and sub-5% interest drive PAT outperformance | | | On target to meet the higher end of volume growth guidance and of reduction in related L&A | | | Strategy: Long-term aim set high and wide | |
| Dr Reddy's Laboratories: Marginal boost, though thesis intact |
| | Good on revenues, poor on margins | | | Expect US business to remain under pressure in 2HFY17 | | | Hopes high on FDA re-inspection, but the absence of a pipeline is more worrying - SELL | |
| Zee Entertainment Enterprises: Steady ship |
| | 2QFY17 - steady operating performance | | | Brace for some softness in advertising and subscription against steep expectations | | | Zee's outperformance versus industry and comfort on profitability stays | |
| IDEA: Tough prognosis, tougher to value; we remain believers |
| | Key changes to our earnings model | | | Read-through from Bharti's results | | | Overall view: brace for challenges ahead | |
| Shriram Transport: In-line results, weak outlook |
| | Weak outlook | | | Lower estimates and price target; management changes may weigh in | |
| Mahindra & Mahindra Financial: Another weak quarter |
| | Strong growth was the only positive | | | NPLs continue to trend up | | | Retain REDUCE with TP of Rs315 | |
| Federal Bank: Another good quarter |
| | Earnings growth led by healthy growth in operating profits | | | Many positive takeaways | | | Maintain BUY rating; good performance raises expectations of better times ahead | |
| Adani Power: Still struggling |
| | Tiroda generation ramps up, though losses remain | | | Imported coal prices have risen 46% since June 2016, will increase cash cost of generation | | | Maintain SELL with target price of Rs26/share | |
| Jyothy Laboratories: Mixed performance; revenue growth decelerates |
| | 2QFY17 print - revenue growth disappoints; EBITDA/PAT growth healthy | | | Ujala, Maxo and Margo disappoint; dishwash and Henko continue to deliver | | | Henkel 'call' renders fundamentals irrelevant. Retain Not Rated rating | |
| Hexaware Technologies: Focus areas drive impressive outperformance |
| | Strong quarter; revenue growth of 4.8% (c/c) led by top 5 accounts | | | Growth led by strategic focus areas | | | Announces a small buyback. Maintain positive view | |
| Rallis India: Improving growth outlook |
| | Ag-chem business returns to strong growth path | | | Improved growth outlook in domestic and export markets | | | Valuation: Reduce estimates slightly but increase TP to Rs250 (Rs240 earlier), maintain ADD | |
| Results, Change in Reco |
| Asian Paints: Healthy quarter, not much to read either way; downgrade to SELL |
| | 2QFY17 earnings print - decent quarter albeit a tad below estimates | | | Estimates broadly unchanged; continue to find valuations rich - downgrade to SELL | |
--
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to
longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at
https://groups.google.com/group/longterminvestorsresearch.
For more options, visit
https://groups.google.com/d/optout.
No comments:
Post a Comment